Articles

One expert says the action of demodex folliculorum and the composition of the symbiotic microbiota in the skin of patients with rosacea may provide valuable insights into the pathogenesis and pathophysiology of this widespread skin disease.

Pathogens, Microbiota May Impact Rosacea 

A recent study finds that payer sway in a region hurts not only patient care, but also physician pay. 

What Role Will Telehealth Play After COVID-19

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

Next-generation therapies explore solutions other than laser treatments, and are less invasive, safer and require less downtime.

Emerging therapies beyond lasers

John Jesitus is a medical writer based in Westminster, CO.

Half of patients are satisfied with their atopic dermatitis treatment and more than half of patients worry about topical steroid side effects, addiction and withdrawal, according to a recent study.

Half of patients with AD satisfied with treatment

The National Psoriasis Foundation’s (NPF) COVID-19 Task Force has recently published 22 guidance statements related to managing psoriatic disease during the pandemic in the Journal of American Academy of Dermatology (JAAD).

NPF provides disease management guidance during COVID-19

In recently presented data at the 29th annual European Academy of Dermatology and Venereology (EADV) virtual congress, baricitinib demonstrated significant long-term safety and efficacy in treating moderate-to-severe atopic dermatitis. 

Baricitinib demonstrates long-term safety, efficacy for AD

Only half of patients are satisfied with their atopic dermatitis treatment; yet, only about one-third discuss their quality-of-life concerns with their healthcare provider, a recent survey reveals. 

Survey highlights quality of life sentiment among patients with AD

Steven R. Feldman, M.D., Ph.D., describes several tactics based on concepts from behavioral economics that can be implemented in counseling conversations with patients.

Behavioral economics concepts guide tactics to promote patient engagement, treatment compliance 

ICYMI, this week’s edition features a video series on social media use in dermatology, the launch of our new podcast, as well as articles about FDA approvals for acne and cSCC, progress in epidermolysis bullosa, new rosacea management treatment, plus more.

Weekly Roundup: June 22-26

Efforts are underway to identify new therapeutic methods that can offer improved outcomes for patients with hidradenitis suppurativa.

NP and PA